Nilvanstomig
Nilvanstomig (ZG005) is an antibody targeting PD-1 and TIGIT. Nilvanstomig blocks the PD-1/TIGIT pathway, thereby promoting the synergistic activation of T cells and enhancing the anti-tumor activity of NK cells. Nilvanstomig is applicable to relevant research on advanced cervical cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3061475-22-4
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
immunoglobulin (H-gamma4-scFvhk_L-kappa) dimer
Human
PDCD1/PD-1/CD279 & TIGIT
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG4-kappa-[scFv]2
ELISA, FACS, Functional assay
Chemical Information
-
CAS. Nr. 3061475-22-4
-
SMILES
[Nilvanstomig]
-
Synonyms
ZG005
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)